These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29175458)

  • 1. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells.
    Cao R; Wang G; Qian K; Chen L; Ju L; Qian G; Wu CL; Dan HC; Jiang W; Wu M; Xiao Y; Wang X
    Cancer Lett; 2018 Feb; 414():278-293. PubMed ID: 29175458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
    Cheng S; Qian K; Wang Y; Wang G; Liu X; Xiao Y; Wang X
    J Cell Mol Med; 2019 May; 23(5):3724-3736. PubMed ID: 30912275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of
    Hu Q; Wang G; Peng J; Qian G; Jiang W; Xie C; Xiao Y; Wang X
    Biomed Res Int; 2017; 2017():3781904. PubMed ID: 29147649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
    Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD
    Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
    Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
    Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM4SF1 promotes glioma malignancy through multiple mechanisms.
    Zheng YW; Wang M; Zhong ZM; Wu GQ; Zhang T; Chen LL; Li M
    Neoplasma; 2022 Jul; 69(4):859-867. PubMed ID: 35532297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.
    Ma YS; Yu F; Zhong XM; Lu GX; Cong XL; Xue SB; Xie WT; Hou LK; Pang LJ; Wu W; Zhang W; Cong LL; Liu T; Long HD; Sun R; Sun HY; Lv ZW; Wu CY; Fu D
    Mol Ther; 2018 Dec; 26(12):2751-2765. PubMed ID: 30301667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.
    Fu XY; Zhou WB; Xu J
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1829-1840. PubMed ID: 32141552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.
    Park YR; Kim SL; Lee MR; Seo SY; Lee JH; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1915-1927. PubMed ID: 28528497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
    Gao C; Yao H; Liu H; Feng Y; Yang Z
    BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
    Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of
    Cao R; Wang G; Qian K; Chen L; Qian G; Xie C; Dan HC; Jiang W; Wu M; Wu CL; Xiao Y; Wang X
    J Cancer; 2017; 8(12):2282-2295. PubMed ID: 28819432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells.
    Huang YK; Fan XG; Qiu F
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer.
    Cheng S; Wang G; Wang Y; Cai L; Qian K; Ju L; Liu X; Xiao Y; Wang X
    Clin Sci (Lond); 2019 Aug; 133(15):1745-1758. PubMed ID: 31358595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.